Letter to the Editor
Author's reply to: “Detection by screening introduces biases into survival estimates for luminal A-like breast cancer patients”
Anna L.V. Johansson,
Corresponding Author
Anna L.V. Johansson
Cancer Registry of Norway, Oslo, Norway
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Correspondence to: Dr Anna L.V. Johansson, E-mail:
[email protected]Search for more papers by this author Giske Ursin,
Giske Ursin
Cancer Registry of Norway, Oslo, Norway
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Norway
Search for more papers by this author
Anna L.V. Johansson,
Corresponding Author
Anna L.V. Johansson
Cancer Registry of Norway, Oslo, Norway
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Correspondence to: Dr Anna L.V. Johansson, E-mail:
[email protected]Search for more papers by this author Giske Ursin,
Giske Ursin
Cancer Registry of Norway, Oslo, Norway
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Norway
Search for more papers by this author
First published: 01 October 2019
No abstract is available for this article.
References
- 1Bucchi L, Ravaioli A, Mancini S, et al. Detection by screening introduces biases into survival estimates for luminal A-like breast cancer patients. Int J Cancer 2019. [Epub ahead of print].
- 2Johansson ALV, Trewin CB, Hjerkind KV, et al. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer 2019; 144: 1251–61.
- 3Partridge AH, Hughes ME, Warner ET, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 2016; 34: 3308–14.
- 4Falk RS, Hofvind S, Skaane P, et al. Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer 2013; 133: 705–12.
- 5Njor SH, Olsen AH, Blichert-Toft M, et al. Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ 2013; 346: f1064.
- 6Hofvind S, Tsuruda K, Mangerud G, et al. The Norwegian breast cancer screening program, 1996–2016: celebrating 20 years of organised mammographic screening. Oslo: Cancer Registry of Norway, 2017. 72.
- 7Abrahamsson L, Isheden G, Czene K, et al. Continuous tumour growth models, lead time estimation and length bias in breast cancer screening studies. Stat Methods Med Res 2019. https://doi.org/10.1177/0962280219832901 [Epub ahead of print].
- 8Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol 2008; 168: 98–104.
